Thursday, February 21, 2013

New Antibiotic May Treat Skin Infections in Shorter Time - Drugs.com MedNews


Torezolid (also known as TR-701 and now tedizoli) is an oxazolidinone drug being developed by Trius Therapeutics(originator Dong-A Pharmaceuticals) for complicated skin and skin-structure infections (cSSSI), including those caused by Methicillin-resistant Staphylococcus aureus (MRSA). 



No comments: